Eric Andersen - Net Worth and Insider Trading
Eric Andersen Net Worth
The estimated net worth of Eric Andersen is at least $8 Million dollars as of 2026-09-11. Eric Andersen is the of Merrimack Pharmaceuticals Inc and owns about 534,008 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $8 Million. Details can be seen in Eric Andersen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Andersen has not made any transactions after 2023-12-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric Andersen
Eric Andersen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Andersen owns 1 companies in total, including Merrimack Pharmaceuticals Inc (MACK) .
Click here to see the complete history of Eric Andersen’s form 4 insider trades.
Insider Ownership Summary of Eric Andersen
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2023-12-28 | director & other: See Remarks |
Eric Andersen Latest Holdings Summary
Eric Andersen currently owns a total of 1 stock. Eric Andersen owns 534,008 shares of Merrimack Pharmaceuticals Inc (MACK) as of December 28, 2023, with a value of $8 Million.
Latest Holdings of Eric Andersen
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2023-12-28 | 534,008 | 15.13 | 8,079,541 |
Holding Weightings of Eric Andersen
Eric Andersen Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Andersen has made a total of 11 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years, including 11 buys and 0 sells. The most-recent trade in Merrimack Pharmaceuticals Inc is the acquisition of 49,550 shares on December 28, 2023, which cost Eric Andersen around $651,582.
Insider Trading History of Eric Andersen
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Eric Andersen Trading Performance
GuruFocus tracks the stock performance after each of Eric Andersen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Andersen is 13.85%. GuruFocus also compares Eric Andersen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Andersen within 3 months outperforms 11 times out of 22 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eric Andersen's insider trading performs compared to the benchmark.
Performance of Eric Andersen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.72 | | | | | |
| Relative Return to S&P 500(%) | 9.32 | | | | | |
Eric Andersen Ownership Network
Ownership Network List of Eric Andersen
Ownership Network Relation of Eric Andersen
Eric Andersen Owned Company Details
What does Merrimack Pharmaceuticals Inc do?
Who are the key executives at Merrimack Pharmaceuticals Inc?
Eric Andersen is the director & other: See Remarks of Merrimack Pharmaceuticals Inc. Other key executives at Merrimack Pharmaceuticals Inc include director & President Gary L Crocker , director & other: See Remarks Noah G. Levy , and other: See Remarks Newtyn Management, Llc .
Merrimack Pharmaceuticals Inc (MACK) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Merrimack Pharmaceuticals Inc (MACK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merrimack Pharmaceuticals Inc (MACK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Merrimack Pharmaceuticals Inc (MACK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merrimack Pharmaceuticals Inc Insider Transactions
Eric Andersen Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Andersen. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Eric Andersen's mailing address is: Santa Monica X1 90404.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
